Physician profile
Edwin Davison
NPI 1689787905
$2,295.19
in general payments reported to CMS, 2019-2025
18 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $291 · 2021: $412 · 2022: $247 · 2023: $281 · 2024: $539 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $472.97 | 2020-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $223.36 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $213.84 | 2022-2025 | Envista Mx60 Iol, Miebo, Envista Envy Iol |
| Oyster Point Pharma, INC. | $206.85 | 2023-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $153.44 | 2023-2025 | Lumigan, Alphagan P, Vuity |
| Allergan, INC. | $152.90 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $148.55 | 2019-2023 | |
| Omeros Corporation | $120.73 | 2021 | |
| Sun Pharmaceutical Industries INC. | $116.33 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $109.10 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $101.05 | 2022-2025 | Sion Surgical Instrument, Omni Surgical System |
| Dompe US, INC. | $92.47 | 2022-2025 | Oxervate |
| Harrow Eye, LLC | $81.62 | 2024 | Vevye |
| Shire North American Group INC | $24.01 | 2019 | |
| Thea Pharma INC. | $23.36 | 2025 | Iyuzeh |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $18.97 | 2021 | |
| Biotissue Holdings INC. | $18.40 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Davison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.